Indication
Disseminated intravascular coagulation
Disseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade. Read more about Disseminated intravascular coagulation
45 drugs 23 manufacturers
Drugs that treat it
Common Disseminated intravascular coagulation therapies.
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDisseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade.
It typically occurs secondary to severe underlying conditions such as sepsis, trauma, malignancy, or acute obstetric complications.
Pathophysiologically, widespread intravascular fibrin deposition produces microvascular thrombosis, tissue ischemia, and subsequent multiorgan dysfunction.
As the condition progresses, the ongoing consumption of platelets and clotting factors, often compounded by secondary fibrinolysis, results in a paradoxical, life-threatening hemorrhagic state.
- nih.gov
Disseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade
- nih.gov
Disseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade
- nih.gov
It typically occurs secondary to severe underlying conditions such as sepsis, trauma, malignancy, or acute obstetric complications As the condition progresses, the ongoing consumption of platelets and clotting factors, often compounded by secondary fibrinolysis, results in a paradoxical, life-threatening hemorrhagic state
- nih.gov
It typically occurs secondary to severe underlying conditions such as sepsis, trauma, malignancy, or acute obstetric complications As the condition progresses, the ongoing consumption of platelets and clotting factors, often compounded by secondary fibrinolysis, results in a paradoxical, life-threatening hemorrhagic state
- nih.gov
Pathophysiologically, widespread intravascular fibrin deposition produces microvascular thrombosis, tissue ischemia, and subsequent multiorgan dysfunction
- nih.gov
Pathophysiologically, widespread intravascular fibrin deposition produces microvascular thrombosis, tissue ischemia, and subsequent multiorgan dysfunction
- nih.gov
As the condition progresses, the ongoing consumption of platelets and clotting factors, often compounded by secondary fibrinolysis, results in a paradoxical, life-threatening hemorrhagic state
Personalize your experience
Follow Disseminated intravascular coagulation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.